{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:57:45Z","timestamp":1790913465566,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":159,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101284","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T02:34:36Z","timestamp":1781922876000},"page":"101284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Translational case series comparing next-generation sequencing profiles of primary breast cancer and brain metastases"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8837-117X","authenticated-orcid":false,"given":"Giselle","family":"de Souza Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Delmonico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Helena","family":"Ornellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana Resende","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila Valverde","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabele \u00c1vila","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jess\u00e9 Lopes","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Henrique Lima","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7467","key":"10.1016\/j.ctarc.2026.101284_bib0001","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature12627","article-title":"Tumour heterogeneity in the clinic","volume":"501","author":"Bedard","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101284_bib0002","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41591-021-01233-9","article-title":"Intratumoral heterogeneity in cancer progression and response to immunotherapy","volume":"27","author":"Vitale","year":"2021","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101284_bib0003","article-title":"Systematic review and meta-analysis of breast cancer brain metastasis and primary tumor receptor expression discordance","volume":"3","author":"Kotecha","year":"2021","journal-title":"Neuro-Oncol. Advances"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101284_bib0004","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/medicina61040563","article-title":"Incidence and prognostic significance of hormonal receptors and HER2 status conversion in recurrent breast cancer: a retrospective study in a single institute","volume":"61","author":"Yousef","year":"2025","journal-title":"Medicina"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101284_bib0005","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/neuonc\/noaa285","article-title":"The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis","volume":"23","author":"Kuksis","year":"2021","journal-title":"Neuro-Oncol."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101284_bib0006","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJMoa1914609","article-title":"Tucatinib, Trastuzumab, and Capecitabine for HER2-positive metastatic breast cancer","volume":"382","author":"Murthy","year":"2020","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ctarc.2026.101284_bib0007","first-page":"1","article-title":"Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b\/4 trial","author":"Harbeck","year":"2024","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101284_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-27987-5","article-title":"Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities","volume":"13","author":"Cosgrove","year":"2022","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101284_bib0009","article-title":"Breast cancer brain metastases genomic profiling identifies alterations targetable by immune-checkpoint and PARP inhibitors","volume":"8","author":"Giannoudis","year":"2024","journal-title":"npj Precision Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101284_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.105507","article-title":"Gene expression profiling in a retrospective real-world cohort of breast cancer brain metastases and paired primary tumors identifies biological changes with potential therapeutic implications","volume":"10","author":"Griguolo","year":"2025","journal-title":"ESMO Open"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101284_bib0011","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med. : Off. J. Am. College of Med. Genet."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101284_bib0012","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s41416-021-01424-8","article-title":"Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies","volume":"125","author":"Wang","year":"2021","journal-title":"British J. Cancer"},{"issue":"7418","key":"10.1016\/j.ctarc.2026.101284_bib0013","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Koboldt","year":"2012","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101284_bib0014","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","article-title":"Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets","volume":"5","author":"Brastianos","year":"2015","journal-title":"Cancer Discovery"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101284_bib0015","article-title":"BRCA1 and BRCA2 mutations and treatment strategies for breast cancer","volume":"4","author":"Godet","year":"2017","journal-title":"Integrat. Cancer Sci. Therapeut."},{"key":"10.1016\/j.ctarc.2026.101284_bib0016","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J. Clin. Epidemiol."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101284_bib0017","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"JCO"},{"issue":"22","key":"10.1016\/j.ctarc.2026.101284_bib0018","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1200\/JCO.22.02864","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: ASCO\u2013college of American pathologists guideline update","volume":"41","author":"Wolff","year":"2023","journal-title":"JCO"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101284_bib0019","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/neuonc\/noaa013","article-title":"Subtype switching in breast cancer brain metastases: a multicenter analysis","volume":"22","author":"Hulsbergen","year":"2020","journal-title":"Neuro-Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101284_bib0020","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.nec.2020.06.002","article-title":"The role of stereotactic biopsy in brain metastases","volume":"31","author":"Yu","year":"2020","journal-title":"Neurosurg. Clin. North Am."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101284_bib0021","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2015-000024","article-title":"Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers","volume":"1","author":"Berghoff","year":"2016","journal-title":"ESMO Open"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101284_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.clbc.2026.03.002","article-title":"Real-world evidence of immunohistochemical discordance in breast cancer brain metastases","volume":"26","author":"Carvalho","year":"2026","journal-title":"Clin. Breast Cancer"},{"issue":"14","key":"10.1016\/j.ctarc.2026.101284_bib0023","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1093\/nar\/gkad519","article-title":"A critical spotlight on the paradigms of FFPE-DNA sequencing","volume":"51","author":"Steiert","year":"2023","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.ctarc.2026.101284_bib0024","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.humpath.2018.10.005","article-title":"Subtypes in BRCA-mutated breast cancer","volume":"84","author":"S\u00f8nderstrup","year":"2019","journal-title":"Human Pathology"},{"key":"10.1016\/j.ctarc.2026.101284_bib0025","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2147\/CMAR.S348529","article-title":"Mutational analysis of BRCA1 and BRCA2 genes in breast cancer patients from eastern sicily","volume":"Volume 14","author":"Stella","year":"2022","journal-title":"Cancer Manage. Res."},{"key":"10.1016\/j.ctarc.2026.101284_bib0026","doi-asserted-by":"crossref","unstructured":"Schick J, Ritchie RP, Restini C. Breast cancer therapeutics and biomarkers: past, present, and future approaches. breast cancer: basic and clinical research. 2021;15:117822342199585.","DOI":"10.1177\/1178223421995854"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101284_bib0027","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-Ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"New Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101284_bib0028","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ctarc.2026.101284_bib0029","article-title":"The role of PI3K in met driven cancer: a recap","volume":"5","author":"Hervieu","year":"2018","journal-title":"Front. Molecul. Biosci."},{"issue":"20","key":"10.1016\/j.ctarc.2026.101284_bib0030","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","article-title":"Alpelisib for PIK3CA-mutated, hormone receptor\u2013positive advanced breast cancer","volume":"380","author":"Andr\u00e9","year":"2019","journal-title":"New Engl. J. Med."},{"issue":"22","key":"10.1016\/j.ctarc.2026.101284_bib0031","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa2214131","article-title":"Capivasertib in hormone receptor-positive advanced breast cancer","volume":"388","author":"Turner","year":"2023","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ctarc.2026.101284_bib0032","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJMoa2501796","article-title":"Overall survival with Inavolisib in PIK3CA -mutated advanced breast cancer","volume":"393","author":"Jhaveri","year":"2025","journal-title":"New Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101284_bib0033","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.48814","article-title":"Association of PIK3CA mutation with pathologic complete response and outcome by hormone receptor status and intrinsic subtype in early-stage ERBB2\/HER2-positive breast cancer","volume":"6","author":"Zagami","year":"2023","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101284_bib0034","article-title":"Breast cancer progression by the FGF\/FGFR axis: a metabolic perspective","volume":"31","author":"Tuokkola","year":"2026","journal-title":"J. Mammary Gland Bio. Neoplasia"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101284_bib0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72818-6","article-title":"Detection of genomic alterations in breast cancer with circulating tumour DNA sequencing","volume":"10","author":"Kleftogiannis","year":"2020","journal-title":"Scientif. Reports"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101284_bib0036","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3233\/CBM-171161","article-title":"ESR1 and PIK3CA mutational status in serum and plasma from metastatic breast cancer patients: A comparative study","volume":"22","author":"Takeshita","year":"2018","journal-title":"Cancer Biomarkers"},{"key":"10.1016\/j.ctarc.2026.101284_bib0037","first-page":"9","article-title":"Diagnostic value of concentration of circulating cell-free DNA in breast cancer: a meta-analysis","author":"Yu","year":"2019","journal-title":"Front. Oncology"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101284_bib0038","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3390\/diseases13100336","article-title":"Molecular analysis of cerebrospinal fluid tumor-derived DNA to Aid in the diagnosis and targeted treatment of breast cancer brain metastasis","volume":"13","author":"Youssef","year":"2025","journal-title":"Diseases"},{"key":"10.1016\/j.ctarc.2026.101284_bib0039","article-title":"Divergence of DNA tumor mutations in cerebrospinal fluid in metastatic breast cancer patients with leptomeningeal metastases","volume":"104674","author":"Wessels","year":"2025","journal-title":"The Breast"},{"issue":"7964","key":"10.1016\/j.ctarc.2026.101284_bib0040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41586-023-06054-z","article-title":"Pan-cancer whole-genome comparison of primary and metastatic solid tumours","volume":"618","author":"Mart\u00ednez-Jim\u00e9nez","year":"2023","journal-title":"Nature"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:47:41Z","timestamp":1790912861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226001954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":40,"alternative-id":["S2468294226001954"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101284","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translational case series comparing next-generation sequencing profiles of primary breast cancer and brain metastases","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101284"}}